GERMANTOWN, Md., Jan. 27, 2016 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company using neural stem cell technology to develop regenerative therapies and small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results